Abiopharma

🔍 von Heynitz Harald (Director)

Company: Fluence Energy, Inc. (FLNC)

Report Date: 2026-03-17

Detailed Transactions and Holdings:

• Acquired 32,348 shares of Class A Common Stock (Direct)
  Date: 2026-03-17 | Code: M | equity_swap_involved: 0 | shares_owned_after: 73,550.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 10,000 shares of Class A Common Stock at $16.5019 per share (Direct)
  Date: 2026-03-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 63,550.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 32,348 shares of Restricted Stock Unit (Derivative)
  Date: 2026-03-17 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F4, F4

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.
• F2: The sales reported on this Form 4 represent the number of shares sold by the Reporting Person to cover tax obligations in connection with the vesting of RSUs.
• F3: This transaction was executed in multiple trades at prices ranging from $16.49 to $16.56, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
• F4: The RSUs vested in full on March 17, 2026. The RSUs had no expiration date.